Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2200166	Pralsetinib胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2022-10-22		Catalent Cts LLC;F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2101092	Pralsetinib胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2021-11-10		Catalent Cts LLC;Blueprint Medicines Corp			view
JTH2000151	Pralsetinib胶囊	pralsetinib	Capsule	Chemical Drugs	Disposable Import Drug Application	2020-05-22	Catalent CTS, LLC	Catalent Cts LLC;Blueprint Medicines Corp;Cornerstone Pharmaceutical (Suzhou) Co Ltd	Certificate Issued	2020-06-19	view
JXHL2000020	Pralsetinib胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Import Drug Application	2020-02-19	基石药业（苏州）有限公司	Cornerstone Pharmaceutical (Suzhou) Co Ltd;Blueprint Medicines Corp	In Review	2020-02-18	view